MyndBlue

MyndBlue is an active French MedTech company specializing in the use of artificial intelligence and physiological data to predict relapses in major depressive disorder (MDD) and post-traumatic stress disorder (PTSD). Their core offering is a predictive digital platform that provides clinicians with real-time alerts about patient status changes based on objective biosignatures collected remotely. This approach aims to enable earlier interventions before full-blown relapses occur. As of mid–2023, they are presenting promising research findings but do not appear to have reached commercial launch or regulatory approval stages yet.